Description

UW Positive Research research efforts are directed by cutting-edge science and guided by local and global Community Advisory Board input. Our intention is to conduct rigorous investigations predominantly focused on HIV treatment, HIV remission/cure, and comorbidities and co-infections associated with HIV. We will achieve our goals by partnering with patients and providers throughout the University of Washington, along with other collaborating institutions and community-based organizations, placing an emphasis on the participation of marginalized communities such as gender-diverse and BIPOC populations in our work at all levels. Specific areas of research focus include:
-Optimizing antiretroviral therapy (ART) strategies to improve ease of use and reduce side effects, especially and including long-acting ART
-Improving immune responses to HIV, including HIV remission strategies and work along the pathway to HIV cure Treating and preventing co-infections, including hepatitis viruses, CMV, tuberculosis, and COVID-19
-Addressing the complexities of aging with HIV, including the metabolic complications of HIV and ART, as well as neurocognitive changes
-Developing treatment for HIV-associated cancers, including immunotherapy Investigating treatment strategies for other conditions impacting people with HIV, including treatments for substance use disorders

Partners

UW School of Pharmacy, Department of Laboratory Medicine, Department of Medicine, Department of Neurology;

UW/Fred Hutch Center for AIDS Research, Seattle Clinical Trials Unit

Funders

National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) 2007-2027
Individual studies supported by the National Institute of Drug Abuse (NIDA), the Cancer Immunotherapy Trials Network (CITN and NCI), and partners in industry